Latest News

Iktos announces the appointment of Dr. Ashiq H. Khan as Chief Business Officer

Iktos announces the appointment of Dr. Ashiq H. Khan as Chief Business Officer

Read the article09.03.2025

Press release

Iktos announces the appointment of Dr. Ashiq H. Khan as Chief Business Officer
09.03.2025

Iktos announces the appointment of Dr. Ashiq H. Khan as Chief Business Officer

Iktos brings Makya, its AI-Driven Drug Design Tool, to the AWS Marketplace
05.06.2025

Iktos brings Makya, its AI-Driven Drug Design Tool, to the AWS Marketplace

Iktos Secures Prestigious EIC Accelerator Grant to Advance its Automated AI and Robotics Platform for Drug Discovery
02.20.2025

Iktos Secures Prestigious EIC Accelerator Grant to Advance its Automated AI and Robotics Platform for Drug Discovery

Press articles and news

Nine promising small molecule drug discovery companies to look out for in 2025

Nine promising small molecule drug discovery companies to look out for in 2025

We are proud to be featured in Labiotech.eu’s roundup of “9 Small Molecule Drug Discovery Companies to Look Out for in 2025”!

Read the article
LaBiotech.eu |05.16.2025
Nine promising small molecule drug discovery companies to look out for in 2025
LaBiotech.eu | 05.16.2025

Nine promising small molecule drug discovery companies to look out for in 2025

Medicinal chemistry: the next step for AI-designed drugs
Manufacturing Chemist | 05.12.2025

Medicinal chemistry: the next step for AI-designed drugs

Nicolas Do Huu: «Avec l’IA, Iktos veut réduire de moitié le temps de découverte des médicaments»
Le Figaro | 02.11.2025

Nicolas Do Huu: «Avec l’IA, Iktos veut réduire de moitié le temps de découverte des médicaments»

Press Kit

Logos
LogosDownload
Photographies
PhotographiesDownload
Contact

Contact

For any communication need please contact our agency.

Ulysse Communication
Mail :  iktosteam@ulysse-communication.com
Tel. : +33663665922